FY25. Consulting services in relation to medical device development under blueprint medtech initiative - subject matter expert in medical device research and development POP: 12/06/24 - 12/05/25
Active Purchase Order Awarded Last action
- Contract number
- 75N95025P00042
- Awardee
-
Luminescent Consulting LLC UEI UP3DVNCPHQL6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,300
Award facts
- Contract value 33% obligated
-
- $15,300.00 Current, with exercised options
- $46,800.00 Potential, with all options
- Completion date 64% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Woman-Owned Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Time and Materials
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $7,800 | |
| Original award | $7,500 |
About this award
The National Institute on Drug Abuse (NIDA) awarded a purchase order contract to Luminescent Consulting LLC, a woman-owned small business, on December 6, 2024, for consulting services related to medical device development under the Blueprint Medtech Initiative. The contract utilizes time and materials pricing with a ceiling value of $46,800 and covers two periods of performance: one extending through December 5, 2025, and another through December 5, 2026, with an ultimate completion date of December 5, 2027. The contractor will serve as a subject matter expert in medical device research and development, performing work at the agency's location in Rockville, Maryland.
This engagement supports NIDA's Blueprint Medtech Initiative, which focuses on accelerating the development and commercialization of medical devices relevant to drug abuse prevention, treatment, and recovery. By engaging specialized consulting expertise in device R&D, NIDA aims to bridge the gap between research innovation and practical medical device solutions that address substance use disorders and related public health priorities. The woman-owned small business set-aside designation reflects the government's commitment to supporting underrepresented business categories in federal contracting.
Quick answers
Who was awarded contract 75N95025P00042?
75N95025P00042 was awarded to Luminescent Consulting LLC by National Institute on Drug Abuse (National Institutes of Health) on December 6, 2024.
How much is contract 75N95025P00042 worth?
The government has obligated $15,300 on 75N95025P00042. Its potential value, with all options, is $46,800.
Was contract 75N95025P00042 competed?
The extent of competition for 75N95025P00042 was competed under sap. The government received 1 offer. It was set aside: Woman-Owned Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award